Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fractyl Health, Inc. (GUTS : NSDQ)

• Company Description    Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA. Number of Employees: 107

• Price / Volume Information    Yesterday's Closing Price: $2.24 Daily Weekly Monthly 20 Day Moving Average: 3,668,466 shares Shares Outstanding: 137.04 (millions) Market Capitalization: $306.98 (millions) Beta: 1.96 52 Week High: $3.03 52 Week Low: $0.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 56.64% 53.33% 12 Week 125.88% 121.81% Year To Date 8.74% -6.18%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3 VAN DE GRAAFF DRIVE SUITE 200 - BURLINGTON,MA 01803 USA ph: 781-902-8800 fax: - ir@fractyl.com http://www.fractyl.com

• General Corporate Information    Officers Harith Rajagopalan - Co-Founder; Chief Executive Officer and Director Lisa A. Davidson - Chief Financial Officer and Treasurer Kelly Barnes - Director William W. Bradley - Director Samuel Conaway - Director Peer Information Fractyl Health, Inc. (GSAC) Fractyl Health, Inc. (CASI) Fractyl Health, Inc. (ALCD.) Fractyl Health, Inc. (OMNN) Fractyl Health, Inc. (CGPI.) Fractyl Health, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 35168W103 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/02/26 Share - Related Items Shares Outstanding: 137.04 Most Recent Split Date: (:1) Beta: 1.96 Market Capitalization: $306.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.07 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 37.26% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/02/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 3,300.84 EPS Growth vs. Year Ago Period: 27.08% vs. Previous Quarter: 33.96% Sales Growth vs. Year Ago Period: -57.14% vs. Previous Quarter: -78.57% ROE 09/30/25 - -2,896.77 06/30/25 - -584.35 03/31/25 - -228.66 ROA 09/30/25 - -105.72 06/30/25 - -102.88 03/31/25 - -76.74 Current Ratio 09/30/25 - 4.27 06/30/25 - 1.22 03/31/25 - 2.50 Quick Ratio 09/30/25 - 4.27 06/30/25 - 1.22 03/31/25 - 2.50 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - -4,073,233.50 06/30/25 - -586,864.69 03/31/25 - -148,511.67 Book Value 09/30/25 - -0.02 06/30/25 - -0.37 03/31/25 - 0.13 Inventory Turnover 09/30/25 - 0.00 06/30/25 - 0.19 03/31/25 - 0.59 Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - 4.61 Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - 82.17

Powered by Zacks Investment Research ©